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ABSTRACT
Objective There is no standard method of publishing the code ranges in research 
using routine data. We report how code selection affects the reported prevalence 
and precision of results.
Design We compared code ranges used to report the impact of pay-for-per-
formance (P4P), with those specified in the P4P scheme, and those used by 
our informatics team to identify cases. We estimated the positive predictive 
values (PPV) of people with chronic conditions who were included in the study 
population, and compared the prevalence and blood pressure (BP) of people 
with hypertension (HT).
Setting Routinely collected primary care data from the quality improvement in 
chronic kidney disease (QICKD—ISRCTN56023731) trial.
Main outcome measures The case study population represented roughly 85% 
of those in the HT P4P group (PPV = 0.842; 95%CI = 0.840–0.844; p < 0.001). We 
also found differences in the prevalence of stroke (PPV = 0.694; 95%CI = 0.687–
0.700) and coronary heart disease (PPV = 0.166; 95%CI = 0.162–0.170), where the 
paper restricted itself to myocardial infarction codes.
Results We found that the long-term cardiovascular conditions and codes 
selected for these conditions were inconsistent with those in P4P or the QICKD 
trial. The prevalence of HT based on the case study codes was 10.3%, com-
pared with 11.8% using the P4P codes; the mean BP was 138.3 mmHg (standard 
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deviation (SD) 15.84 mmHg)/79.4 mmHg (SD 10.3 mmHg) and 137.3 mmHg (SD 
15.31)/79.1 mmHg (SD 9.93 mmHg) for the case study and P4P populations, 
respectively (p < 0.001).
Conclusion The case study lacked precision, and excluded cases had a lower 
BP. Publishing code ranges made this comparison possible and should be man-
dated for publications based on routine data. 
Keywords: clinical coding, computerised, heart diseases, hypertension, incentive, 
medical records system, reimbursement, research design
BACKGROUND AND SIGNIFICANCE
‘Comparing apples with oranges’
Standard methods of reporting research are well established 
and widely accepted, though currently there is no guidance 
on publishing code ranges for papers based on routine data. 
The Consolidated Standards of Reporting Trials (CONSORT) 
statement set out clear guidance and led to the development 
of checklists for the reporting of trials.1 This statement has 
not only influenced the reporting of trial but also led to the 
development of more systematic schema planning and 
reporting of other kinds of studies, brought together in the 
EQUATOR Network.2 However, neither EQUATOR nor 
CONSORT contains much about computerised data quality. 
Stare-HI contains guidelines pertinent to health informatics 
evaluation, but is similarly silent on code ranges.3
Data in computerised medical records (CMRs) are in two 
forms: coded data—where an important diagnosis or symp-
tom is represented by a machine–interpretable code, or as 
free text. Codes are used for a lot more than  diagnoses. For 
example, they are also used to record examination findings, 
test results,  procedures, medications, and  allergies. Nearly all 
CMRs code important information, so data can be searched 
and linked. Free text is difficult to process because clinical 
notes often contain qualifiers before words (e.g. unlikely 
bowel cancer and fear of cancer) and have multiple near 
synonyms (e.g. coronary heart disease (CHD) and  ischaemic 
heart disease). 
 Internationally, there are a variety of coding systems avail-
able, such as Systematic nomenclature of Medicine—Clinical 
Terms and International Classification of Diseases (ICD), 
currently at version 10 (ICD 10). The most used terminology 
in the UK primary care is the Read terminology version 2 
(Read 2); however, a more complex terminology Read clinical 
terms version 3 (CTV3) is also used by some CMR vendors.4
OBJECTIVE
A recent review concluded that there was insufficient 
 evidence that pay-for-performance (P4P) had improved the 
quality of care in hypertension (HT),5 and we have published 
on critique of its findings.6 However, on reflection, we feel 
there is a major opportunity to improve the standards of the 
reporting of research studies based on routinely collected 
data. Fortunately, the authors of this paper have published 
the code ranges they used to define the long-term conditions 
in the case study. We carried out this analysis to explore 
whether the code ranges selected in our case study would 
identify the people with the long-term cardiovascular condi-
tions listed correctly, and whether there was any difference in 
blood pressure (BP) between these different groups. 
METHOD
We compared the code ranges used in the case study with 
those used by the P4P program and those used by a clini-
cal informatics group to identify people with these conditions 
from routinely collected data.
First, we identified the reference terminology used in the 
case study and a justification for the code ranges used within 
the reference terminology. We next explored the code ranges 
used in the case study paper, and compared with the range 
of codes available within the coding system, using the NHS 
code browser.7 We manually searched relevant terms related 
to the conditions used in the case study within the Read 2 
terms, identifying all the relevant terms and their associated 
codes. We compared the use of disease, symptom, proce-
dure, and drug codes that we found with the codes used in 
the case study.
We identified the long-term cardiovascular conditions 
in the P4P scheme that correspond to the conditions 
described in the case study. We extracted the inclusion 
and exclusion code ranges for each condition category 
from the P4P business rules, which are available online.8 
We also compared the codes used in the case study 
with those used by our clinical informatics team to detect 
these same long-term conditions from routinely collected 
data. The routine data were a convenience sample, those 
extracted for the quality improvement in chronic kidney dis-
ease (QICKD) trial.9,10
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We looked at which codes are included and excluded in 
the case study, P4P, and the QICKD trial, and created a 
Venn diagram of codes. We then compared the prevalence 
of disease that would be identified using the case study code 
ranges with the prevalence calculated using routine (QICKD 
trial) data, prevalence using P4P code ranges in QICKD 
data, and nationally stated P4P prevalence. National P4P 
prevalence is publicly available.11 For chronic kidney disease 
(CKD), the QICKD study team identified the prevalence of 
people with CKD using renal function test measures, extract-
ing value ranges associated with three procedure codes 
(451E—glomerular filtration rate calculated by abbreviated 
Modification of Diet in Renal Disease Study Group calcula-
tion, 44J3—serum creatinine, and 44JF—plasma creatinine 
level) for CKD.12
We explored a single P4P year, 2009–2010, to see if BPs 
were different between case study, P4P indicator popula-
tions and the QICKD trial population with HT. We report the 
mean and standard deviation (SD), and use an independent 
samples t-test to compare the mean systolic and diastolic 
BP for the people identified by the case study codes with 
the BP of the people in the two groups (i.e. people with HT 
identified by P4P but not included in the case study and peo-
ple identified as having HT in the QICKD trial but not in the 
case study). We also report the overall population BP for the 
case study codes compared with the QICKD trial more com-
prehensive codes.
We analysed the data in SPSS (PASW—IBM Statistics) 
version 18. We calculated the positive predictive values of 
a person being identified as having the disease based on 
routine data; we repeated this process for the P4P indicator 
group compared with the study population. We quote 95% 
confidence for the predictive values (95%CI). We also quote 
the p-values for the two-by-two contingency tables using 
chi-squared.
The QICKD trial is ethically approved (Clinical Trials 
Registration: ISRCTN56023731). P4P and the other data 
used in this paper are publicly available. 
RESULTS
The case study used the Read 2 coding classification as its 
terminology rather than CTV3 as stated, and used a limited 
subset of the available terms. Consequently, we also report 
our findings making comparisons with the Read 2 code sys-
tem. The code ranges included in the study were limited and 
did not include all the code ranges for each of the conditions 
specified (Table 1). Apart from CKD, the rest of the conditions 
in the study did not include any history/symptoms codes. The 
case study included most but not all of the major codes for 
the conditions studied.
Although we were able to find the P4P conditions that 
matched the ones described in the case study [HT and 
heart failure (HF)], we could not find the matching cat-
egories for myocardial infarction (MI) and renal failure 
(RF) (Table 2). The nearest corresponding conditions in 
P4P were CHD and CKD. The case study only referred to 
stroke, whereas P4P includes stroke and transient isch-
aemic attack (TIA).
Although the case study examined the effect of P4P, the 
code selection used in the case study was inconsistent with 
the code range listed under P4P business rules. The HT 
codes selected did not include G2 (hypertensive disease) 
(Figure 1). The HT codes used in the study also included car-
diac disease monitoring codes (662) that would be classified 
under codes for HF in P4P. Most codes within the 662 hierar-
chy are not consistent with HT. 
The case study describes using ‘RF’ rather than CKD 
codes. CKD, not RF, is included in P4P, and codes that the 
authors included are CKD codes (1Z1), and not RF codes. 
However, the code selection in the case study for ‘RF’ was 
in our opinion too broad. The 1Z1 hierarchy includes all 
CKD codes, including stage 1 and 2 CKDs (normal and 
mildly impaired renal function, respectively);13 neither of 
the latter is included in P4P or QICKD trial data used in 
the analysis. Also for RF, the authors included hyperten-
sive renal disease codes (G22), and for HF, they included 
hypertensive heart and renal disease (G23), neither of 
which is included in either P4P nor considered appropriate 
to include in QICKD trial queries. The codes used for RF 
in the case study include chronic and unspecified RF (K05 
and K06) but not acute RF (K04). 
The code ranges used in the case study are generally a 
subset of the codes ranges used by the clinical informatics 
team in the QICKD trial. There were codes in the case study 
that were inappropriately included in the case study but not 
in QICKD or P4P. These were 662 for HT monitoring, G23 for 
HF, and G22 for CKD. The case study and P4P did include 
some codes not included in the QICKD trial. 
The case study used some codes whose use, we antic-
ipate, would result in an overestimate of the prevalence 
of cerebrovascular disease. These were vertebral artery 
syndrome (G651), subclavian steal syndrome (G652), 
and vertebrobasilar insufficiency (G656); the QICKD study 
does not include them because we see them used in rou-
tine practice to record clinical diagnoses that might not 
represent true cerebral ischaemia; the latter is commonly 
diagnosed clinically in older people with unsteadiness or 
looking upwards. 
With the exception of CKD/RF, the prevalence rates 
reported in the case study are lower than QICKD and P4P 
prevalence rates predicted from routine data. The biggest 
discrepancy is for MI and CHD mismatch, where the case 
study had a prevalence of 0.48% compared with 2.92% for 
QICKD, 2.31% for P4P, and 3.44% for the nationally stated 
P4P. This is mainly due to the case study only selecting codes 
for MI rather than for CHD. HF showed the most agreement 
between the case study and P4P and QICKD differing by up 
to 0.02%. 
We estimate that, in HT, the cases included in the case 
study are about 85% of those in the P4P population, and 83% 
of those identified as having HT in the QICKD trial due to 
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Table 2 Conditions and codes used in the case study compared with those in P4P
Conditions in the case study
Conditions in P4P (QOF)* 
business rules Codes in the case study Codes in P4P (QOF)* business rules
HT Established HT G20, 662 G2, G20%, G24–G2z (exc. G24z1)
MI CHD G30, G34, G35 G3–G330z, G33z–G3401, G342–G366,  
G38–G3z, Gyu3%
Stroke Stroke and TIAs G61, G64–68 G61% (exc G617), G63y0–G63y1, G64%, G66%, 
G6760, G6W, G6X, Gyu62–Gyu66, Gyu6F, 
Gyu6G (stroke); G65–G654, G656–G65zz, 
F4236 (TIA)
HF HF G23, G58 G58%, G1yz1, 662f–i
RF CKD G22, 1Z1, K05, K06 1Z12–6, 1Z1B–1Z1L
*P4P = pay for performance; QOF = quality and outcomes framework (the UK P4P scheme to improve chronic disease management)
G20%-
Essential HT
P4P (QOF)
Case Study
QICKD
HT (NS & sense organ diseases)
(F282, F4042, F4213)
Hypertensive diseases code
(G21-23%, G24z1, G672)
L12% - HT complicating
pregnancy, childbirth and the 
puerperium
662% - Cardiac
disease monitoring+
Hypertensive
disease codes (G2, 
G24%*, G2y-z%)
Figure 1 Venn diagram of codes for HT
the difference in the selection of codes. The large mismatch 
between MI and CHD means that the case study only identi-
fied around 21% of people with CHD based on the P4P regis-
ter codes and 17% of those identified with the broader range 
of QICKD trial codes; the biggest difference is the use of 
codes G2, G2z, and G2y for ‘hypertensive disease’, ‘hyper-
tensive disease not otherwise specified (NOS),’ and ‘other 
specified hypertensive disease’, respectively. These codes 
represent around 12% of coding, and it is likely that most 
are people with essential HT. The matches for stroke and HF 
were much closer. In CKD, the case study used the whole 
of the 1Z1 hierarchy, so it would have found all the cases of 
CKD coded; however, this vastly exceeded the national P4P 
prevalence as it also included CKD classes. The QICKD trial 
found that disease codes were unreliable, so it used labo-
ratory recordings of renal function, thereby identifying more 
cases and reporting a higher prevalence than was identified 
by the P4P indicator.11 This is a special case because CKD is 
a relatively newly recognised condition (Table 3).14
With the exception of CKD, the negative predictive  values 
were close to parity. This is because there were a very small 
number of people who were included in the case study 
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Table 3 Prevalence and PPV of the five conditions using different measures of code selection*
Condition Study Prevalence (%) No. of cases
PPV (95 CI)
Case study/P4P Case study/QICKD
HT
Case study 10.27 112,895
0.842 
(0.840, 0.844)
0.826 
(0.824, 0.828)
QICKD 12.07 132,681
P4P 11.83 130,082
P4P national  (09/10) 13.35  
Stroke  
(and TIA)
Case study 1.25 13,693
0.963 
(0.960, 0.966)
0.694 
(0.687, 0.700)
QICKD 1.79 19,726
P4P 1.25 13,723
P4P national  (09/10) 1.68  
HF
Case study 0.69 7626
0.996 
(0.994, 0.997)
0.980 
(0.976, 0.983)
QICKD 0.71 7782
P4P 0.70 7657
P4P national  (09/10) 1.08  
MI/CHD
Case study 0.48 5325
0.209 
(0.204, 0.214)
0.166 
(0.162, 0.170)
QICKD 2.92 32,054
P4P 2.31 25,352
P4P national  (09/10) 3.44  
RF/CKD
Case study 1.73 16,426
1.000 
(1.000, 1.000)
0.187 
(0.183, 0.191)
QICKD 4.06 38,685
P4P 0.89 8475
P4P national  (09/10) 4.20  
*The results are all statistically significant p < 0.001 (chi-squared)
HT = hypertension, TIA = transient ischaemic attack, HF = heart failure, MI = myocardial infarction, CHD = coronary heart disease, RF = renal failure, CKD = chronic kidney disease
PPV = positive predictive value, P4P = pay-for-performance, QICKD = quality improvement in CKD trial data 
 disease groups who as far as we could tell did not have the 
disease (data not shown).
Our snapshot look at HT demonstrated that people in the two 
excluded groups for codes had lower systolic and diastolic BP. 
The mean systolic and diastolic BPs for the codes included 
in the case study were 138.3 mmHg (n = 87,989, SD 15.84 
mmHg) and 79.4 mmHg (SD 10.3 mmHg). The means for 
the people with non-included codes were 137.3 mmHg (n = 
17,165, SD 15.31 mmHg) and 79.1 mmHg (SD 9.93 mmHg) 
for the group with other P4P codes, and 136.4 mmHg (n = 
18,8898, SD 15.68 mmHg) and 79.1 mmHg (SD 9.95 mmHg) 
for people with other QICKD trial codes. These differences are 
all small but statistically significant (independent samples t-test 
p < 0.001). For the non-included P4P codes, the mean differ-
ence in systolic was 0.9 mmHg (95%CI 0.65–1.17 mmHg), 
and for diastolic, it was 0.4 mmHg (95%CI 0.19–0.52 mmHg) 
lower; and compared with the QICKD trial, the mean differ-
ence in systolic was 1.82 mmHg (95%CI 1.57–2.06 mmHg), 
and for diastolic, it was 0.3 mmHg (95%CI 0.17–0.48 mmHg), 
which are also lower than the values from the case study. 
Had the mean for BP been reported for everyone, with HT 
been reported using the more comprehensive set of codes used 
in the QICKD study, the mean would have been 137.9 mmHg 
(SD 15.83 mmHg) instead of 138.2 mmHg (SD 15.84 mmHg).
DISCUSSION
Principal findings
The publication of code ranges in the case study has allowed us 
to compare the population the authors intended to study with the 
population actually studied; it is likely that they did not include 
around 15% of the cases. Where they looked at other comor-
bidities, they used descriptions or definitions that are different 
in three out of four diseases from the equivalent in the P4P 
scheme. It is likely that they have drawn their conclusions from 
a subset of people included in the P4P scheme and that these in 
turn maybe a subset of the people who actually have the condi-
tion. Our snapshot look at HT suggests that, at the population 
level, there may have been a small but statistically significantly 
different mean BP had all the relevant codes been included. 
Implications of the findings
Implementing a standardised method of publishing the 
code ranges, when using routinely collected data for 
research, and justifying the selection would reduce any 
potential errors in the results that are due to inconsisten-
cies in code selection. Whilst we do not know whether 
including all the relevant codes would have affected the 
outcome of the case study, it demonstrates that there is 
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a difference between groups and a completely avoidable 
loss of precision in the results. Including an informatician 
in the study team may help to reduce the potential for 
errors in code selection.
Comparison with the literature
The literature on comparative effectiveness highlights the 
potential of using routine data for research,15,16 but also 
stresses the importance of recognising its limitations and of 
addressing coding and data quality issues.17 Differences in 
data recording are reported between data found in the CMR 
and those found in the billing system,18 and there is recogni-
tion that a comprehensive set of data is needed to overcome 
these challenges.19
If data are utilised without critical appraisal or taking into 
account the human element of clinical coding, there are 
risks of errors as coding is part of a complex social interac-
tion between a clinician and a patient.20 These data are often 
incomplete21 and subject to the vagaries of the computer 
interface.22 
Data from general practice are usually collected with the 
first and foremost use of improving an individual patient’s 
care; other uses form a hierarchy that needs to be con-
sidered when interpreting data.23 The P4P code ranges 
are a payment scheme that focuses on delivery of quality 
care.24
Many codes do not accurately represent whether or not a 
disease or condition is present in an individual patient.25,26 
We have previously demonstrated this in some detail in the 
case of diabetes, where people were not coded properly and 
were therefore not included in disease registers.27,28 The peo-
ple excluded from the register may not receive the associated 
prompts, and recalls may therefore receive worse care.29
Practices joining data-providing networks such as The 
Health Improvement Network, the database used in the case 
study, have quality screening,30,31 and this may have led 
to selection bias, with the practices having less scope to 
improve as a result of P4P. Token incentives used in a similar 
network did improve data quality.32
Finally, the quality of the extract system can affect data 
quality.
Limitations
This analysis has examined only one study and a limited 
number of conditions. There are no trials or evidence from 
prospective studies that standardising code ranges would 
affect the outcome or conclusion of the case study or other 
studies. Our paper does not aim to question the conclusion 
of the case study. 
It is possible that the QICKD study database is not repre-
sentative of the national population and that the frequency of 
codes found in this study database is not representative of 
national practice; however, as the principal difference in HT 
prevalence was from the failure to use the G2 codes used in 
the P4P business rules, this is unlikely.
Call for further research
New methods are needed for describing the code ranges 
used in studies. We suggest in the interim adopting the 
clinical informatics method. The tables and data dictionary 
Table 4 Exemplar layout of codes listed in a study
Included Excluded
Code category Domain Subdomain Term Code Domain Subdomain Term Code
Disease Circulatory system 
disease
Hypertensive 
disease
Hypertensive  
disease
G2...a     
   Essential HT G20%b     
   Secondary HT G24%b Circulatory 
system 
disease
Hypertensive 
disease
HT secondary 
to drug
G24z1
   Other specified 
hypertensive  
disease
G2y%b     
   Hypertensive  
disease NOS
G2z%b     
Therapy         
History         
Investigation         
Process         
Administrative         
Care         
a% = all sub-codes
b... = specific code only
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developed by the clinical informatics team may provide 
an initial model, whilst more detailed consensus models 
are developed. We suggest that all studies of this nature 
declare and provide a reference terminology, ideally the 
one that can be browsed by others. Authors are also rec-
ommended to use this as a controlled vocabulary, pre-
cisely labelling variables using the rubric displayed (e.g. 
G20 ‘essential HT’). Authors should then list their included 
codes in three levels of granularity: domain, sub-domain, 
and term; and using the same three levels any excluded 
codes (Table 4). We next recommend that a table of code 
mappings be developed where codes from one hierarchy 
or coding system are converted to another, as we have 
demonstrated with ethnicity.33 It is especially in complex 
studies that browsable lists of variables included in the 
study should be made available online. We provide links 
to a downloadable example from the QICKD trial34 and a 
smaller osteoporosis study (Figure 2).35
We suggest a tabular format for representing codes and 
an online browsable format for data dictionaries for study 
 variables, which are part of our standard way of processing 
data for studies based on routine data (Table 4). 
In the longer term, we need to move towards ontological 
methods that need to be developed to define data sets, rather 
than experts producing coding lists, which are simply added to 
or edited by other experts.36,37 An ontology, in  informatics, is 
a set of concepts and relationships, and most conditions can 
be defined by diagnostic criteria and test results, or inferred 
from the use of therapy, and refuted if the demographics or 
other data do not fit for that condition.
CONCLUSIONS
Publishing the code ranges has enabled us to critique the 
premise on which the findings of this paper are based. A fail-
ure to justify why a paper about P4P chose to define clinical 
Figure 2 QICKD data dictionary
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conditions differently from those used in that scheme resulted 
in a loss in the precision of its findings. In the absence of 
other consensus guidance, authors could consider adopt-
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Authors of papers written using routine data should publish 
and justify the code ranges they select. 
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